Articles From: SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Vivint Solar, Inc. and Certain Officers -- VSLR to New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition


2014/11/26
SYDNEY--Woolworths Ltd.
Sign-up for Woolworths Says Share Sell-Off Overdone investment picks
2014/11/26
By Laurie Burkitt BEIJING--
Sign-up for Wal-Mart Stores Inc. Cuts Nearly 30 Directors and Midlevel Managers in China--Spokesman investment picks
2014/12/03
U.S. Market Stocks were mostly higher this morning after economic data.
Sign-up for Stocks Mostly Higher After Data investment picks
2014/12/02
Welcome to Morningstar, where we're dedicated to helping you understand and analyze stocks, funds, and your own portfolio.
Sign-up for Your Guide to Morningstar.com investment picks
2014/12/04
U.S. Market Stocks were lower this morning after the European Central Bank said it will wait until next year to start any new stimulus programs.
Sign-up for Stocks Move Lower After ECB Comments investment picks
2014/12/06
At least a portion of last month's high job growth may be due to overly aggressive seasonal factors.
Sign-up for Something's Not Working in November Jobs Report investment picks
2014/12/06
Bad decision-making and a lack of self-discipline can hamper performance, retired readers say.
Sign-up for Retirees: Avoid These Investing Mistakes investment picks
2014/12/06
The retirement-income tool has its critics, but Alicia Munnell of Boston College's Center for Retirement Research says it makes a lot of sense for many retirees.
Sign-up for In Defense of Reverse Mortgages investment picks
2014/12/06
Be diligent to ensure you're getting the most investment dollars working for you.
Sign-up for How to Find (and Vanquish) Hidden Costs in Your 401(k) investment picks
2014/12/05
U.S. Market Stocks rose today after a stronger-than-expected jobs report.
Sign-up for Stocks End Higher After Strong Jobs Data investment picks
2014/12/04
U.S. Market Stocks pared early losses but still ended today after the European Central Bank said it will wait until next year to start any new stimulus programs.
Sign-up for Stocks Pare Losses But End Lower; ECB in Focus investment picks
2014/12/05
U.S. Market Stocks rose this morning after a stronger-than-expected jobs report.
Sign-up for Stocks Rise After Strong Jobs Data investment picks
2014/12/05
The asset manager's transformation has resulted in profitability that continues to improve.
Sign-up for Invesco's More Complete and Much Stronger investment picks
2014/12/07
Readers say selling losers, giving to donor-advised funds among the ways they'll reduce their tax hit.
Sign-up for How Investors Are Lowering Their 2014 Tax Bills investment picks
2014/12/7
SINGAPORE-Global Logistic Properties Monday said it would take a 55% stake in a venture led by Singapore's sovereign-wealth fund that is acquiring industrial properties worth US$8.1 billion from Blackstone Group.
Sign-up for Global Logistic to Take 55% Stake in GIC Led Venture investment picks
2014/12/7
By Ben Dummett TORONTO-- BlackBerry Ltd.
Sign-up for BlackBerry Plans Medical Tool for Its Passport Smartphone investment picks
2014/12/7
(FROM THE WALL STREET JOURNAL 12/8/14) By Sarah Krouse Low interest rates and a resurgence in mergers and acquisitions this year, particularly big-ticket deals, have companies turning to the bond market like never before.
Sign-up for Deals Fuel Bond Boom investment picks
2014/12/7
By Gaurav Raghuvanshi SINGAPORE-Global Logistic Properties Monday said it would take a 55% stake in a venture led by Singapore's sovereign-wealth fund that is acquiring industrial properties worth US$8.1 billion from Blackstone Group.
Sign-up for Global Logistic Properties: To Buy Properties Worth US$8.1 Billion in U.S. With GIC investment picks
2014/12/7
By Chelsey Dulaney Lululemon Athletica Inc.'s best shot at regaining its spot atop the fitness retailing world could be a $102 pair of tights in a gold-sequins print, or maybe a black-and-white jacket in a dizzying floral print.
Sign-up for Lululemon Offers Flashier Apparel in Bid to Boost Sales investment picks
NEWTOWN, Pa., Dec.
Sign-up for Onconova Announces ONTIME Data Presentations at the 2014 ASH Annual Meeting investment picks
2014/12/7
By Prudence Ho And Enda Curran HONG KONG--Even as they battle souring loans and weak share prices, China's banks have managed to raise a record US$110 billion this year by tapping into investors' desire for yield.
Sign-up for China's Banks Seize on New Debt Option investment picks
SAN RAFAEL, Calif., Dec.
Sign-up for BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Australia for Treatment of Morquio A Syndrome investment picks
-Only Rentrak Provides the Official Global Movie Results- LOS ANGELES , Dec.
Sign-up for Rentrak Announces Official Worldwide Box Office Results for Weekend of December 7, 2014 investment picks
SOUTH SAN FRANCISCO, Calif., Dec.
Sign-up for Sunesis Pharmaceuticals Announces Presentation of Results From Phase 3 VALOR Trial at ASH Annual Meeting investment picks
Durable Responses Observed with Patients on Study for up to Eight Months and Ongoing in Advanced Acute Myeloid Leukemia and Other Blood Cancers SAN FRANCISCO, Dec.
Sign-up for Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- With gas prices at multiyear lows and consumer sentiment at multiyear highs, retail sales data will likely be the main catalyst for stocks this week.
Sign-up for MARKET SNAPSHOT: Retail Sales Data To Confirm Tone Of Holiday Shopping investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin) pivotal Phase 2 clinical trial in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic ALCL, a type of T-cell lymphoma.
Sign-up for Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting investment picks
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the presentation of preliminary data from the luspatercept phase 2 clinical trial in patients with beta-thalassemia at the 56 th American Society of Hematology (ASH) Annual Meeting and Exposition.
Sign-up for New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Vivint Solar, Inc. and Certain Officers -- VSLR to New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent